<pmc-articleset xmlns:ns0="http://www.w3.org/1999/xlink">
<article xml:lang="en" article-type="research-article" dtd-version="1.4">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Am Acad Dermatol</journal-id>
<journal-id journal-id-type="iso-abbrev">J Am Acad Dermatol</journal-id>
<journal-id journal-id-type="pmc-domain-id">319</journal-id>
<journal-id journal-id-type="pmc-domain">nihpa</journal-id>
<journal-title-group>
<journal-title>Journal of the American Academy of Dermatology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0190-9622</issn>
<issn pub-type="epub">1097-6787</issn>
<custom-meta-group>
<custom-meta>
<meta-name>pmc-is-collection-domain</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-collection-title</meta-name>
<meta-value>NIHPA Author Manuscripts</meta-value>
</custom-meta>
</custom-meta-group>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmcid">PMC10238628</article-id>
<article-id pub-id-type="pmcid-ver">PMC10238628.1</article-id>
<article-id pub-id-type="pmcaid">10238628</article-id>
<article-id pub-id-type="pmcaiid">10238628</article-id>
<article-id pub-id-type="manuscript-id">NIHMS1874778</article-id>
<article-id pub-id-type="pmid">36773823</article-id>
<article-id pub-id-type="doi">10.1016/j.jaad.2023.01.035</article-id>
<article-id pub-id-type="manuscript-id-alternative">NIHMS1874778</article-id>
<article-id pub-id-type="manuscript-id-alternative">NIHPA1874778</article-id>
<article-version article-version-type="pmc-version">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical Factors Associated with Skin Neoplasms in Individuals with Lynch Syndrome in a Longitudinal Observational Cohort</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Zhong</surname>
<given-names initials="CS">Connie S.</given-names>
</name>
<degrees>MD, MSc</degrees>
<xref rid="A1" ref-type="aff">1</xref>
<xref rid="A2" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Horiguchi</surname>
<given-names initials="M">Miki</given-names>
</name>
<degrees>PhD</degrees>
<xref rid="A2" ref-type="aff">2</xref>
<xref rid="A3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Uno</surname>
<given-names initials="H">Hajime</given-names>
</name>
<degrees>PhD</degrees>
<xref rid="A2" ref-type="aff">2</xref>
<xref rid="A3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Ukaegbu</surname>
<given-names initials="C">Chinedu</given-names>
</name>
<degrees>MBBS, MPH</degrees>
<xref rid="A2" ref-type="aff">2</xref>
<xref rid="A3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Chittenden</surname>
<given-names initials="A">Anu</given-names>
</name>
<degrees>MS, LGC</degrees>
<xref rid="A2" ref-type="aff">2</xref>
<xref rid="A3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>LeBoeuf</surname>
<given-names initials="NR">Nicole R.</given-names>
</name>
<degrees>MD, MPH</degrees>
<xref rid="A1" ref-type="aff">1</xref>
<xref rid="A2" ref-type="aff">2</xref>
<xref rid="A3" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Syngal</surname>
<given-names initials="S">Sapna</given-names>
</name>
<degrees>MD, MPH</degrees>
<xref rid="A1" ref-type="aff">1</xref>
<xref rid="A2" ref-type="aff">2</xref>
<xref rid="A3" ref-type="aff">3</xref>
<xref rid="FN1" ref-type="author-notes">*</xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Nambudiri</surname>
<given-names initials="VE">Vinod E.</given-names>
</name>
<degrees>MD, MBA, EdM</degrees>
<xref rid="A1" ref-type="aff">1</xref>
<xref rid="A2" ref-type="aff">2</xref>
<xref rid="A3" ref-type="aff">3</xref>
<xref rid="FN1" ref-type="author-notes">*</xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Yurgelun</surname>
<given-names initials="MB">Matthew B.</given-names>
</name>
<degrees>MD</degrees>
<xref rid="A1" ref-type="aff">1</xref>
<xref rid="A2" ref-type="aff">2</xref>
<xref rid="A3" ref-type="aff">3</xref>
<xref rid="FN1" ref-type="author-notes">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Brigham &amp; Women’s Hospital, Boston, MA 02215</aff>
<aff id="A2">
<label>2</label>Harvard Medical School, Boston, MA 02215</aff>
<aff id="A3">
<label>3</label>Dana-Farber Cancer Institute, Boston, MA 02215</aff>
<author-notes>
<fn id="FN1">
<label>*</label>
<p id="P1">Co-senior authors</p>
</fn>
<corresp id="CR1">
<bold>Corresponding author:</bold> Matthew B. Yurgelun, MD, Dana-Farber Cancer Institute, 450 Brookline Avenue, Dana 1126, Boston, MA 02215, <email>matthew_yurgelun@dfci.harvard.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>2</month>
<year>2023</year>
</pub-date>
<issue-id pub-id-type="pmc-issue-id">437329</issue-id>
<elocation-id>S0190-9622(23)00173-1</elocation-id>
<pub-history>
<event event-type="nihms-submitted">
<date>
<day>18</day>
<month>02</month>
<year>2023</year>
</date>
</event>
<event event-type="pmc-release">
<date>
<day>01</day>
<month>06</month>
<year>2024</year>
</date>
</event>
<event event-type="pmc-live">
<date>
<day>01</day>
<month>06</month>
<year>2024</year>
</date>
</event>
<event event-type="pmc-released-under-embargo">
<date>
<day>04</day>
<month>06</month>
<year>2023</year>
</date>
</event>
<event event-type="pmc-last-change">
<date iso-8601-date="2025-04-20 16:25:23.090">
<day>20</day>
<month>04</month>
<year>2025</year>
</date>
</event>
</pub-history>
<self-uri content-type="pmc-pdf" ns0:href="nihms-1874778.pdf" />
<abstract id="ABS1">
<sec id="S1">
<title>Background:</title>
<p id="P2">Little is known about patient-specific risk factors for skin neoplasia in individuals with Lynch Syndrome (LS).</p>
</sec>
<sec id="S2">
<title>Objective:</title>
<p id="P3">Identify clinical factors associated with development of skin neoplasms in LS.</p>
</sec>
<sec id="S3">
<title>Methods:</title>
<p id="P4">Clinical data were systematically collected on a cohort of LS carriers (confirmed pathogenic germline variants [PGVs] in <italic toggle="yes">MLH1</italic>, <italic toggle="yes">MSH2</italic>, <italic toggle="yes">MSH6</italic>, <italic toggle="yes">PMS2</italic>, or <italic toggle="yes">EPCAM</italic>) age ≥18 undergoing clinical genetics care at Dana-Farber Cancer Institute from 1/2000–3/2020. Multivariable logistic regression was performed to evaluate clinical factors associated with skin neoplasia.</p>
</sec>
<sec id="S4">
<title>Results:</title>
<p id="P5">Of 607 LS carriers, 9.2% had LS-associated skin neoplasia and 15.0% had non-LS-associated skin neoplasia. 58.2% (353/607) had documentation of prior dermatologic evaluation. 29.7% (38/128) with skin neoplasms lacked a history of visceral LS-associated malignancy. LS-associated skin neoplasms were significantly associated with male sex, age, race, <italic toggle="yes">MLH1</italic> PGVs, <italic toggle="yes">MSH2/EPCAM</italic> PGVs, and personal history of non-LS skin neoplasms. Non-LS-associated skin neoplasms was significantly associated with age, number of first- and second-degree relatives with non-LS-associated skin neoplasms, and personal history of LS-associated skin neoplasms.</p>
</sec>
<sec id="S5">
<title>Limitations:</title>
<p id="P6">Single-institution observational study; demographic homogeneity.</p>
</sec>
<sec id="S6">
<title>Conclusions:</title>
<p id="P7">Skin neoplasms are common in individuals with LS. We identified clinical factors associated with LS- and non-LS-associated skin neoplasms. Regular dermatologic surveillance should be considered for all LS carriers.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Muir-Torre syndrome</kwd>
<kwd>sebaceous</kwd>
<kwd>keratoacanthoma</kwd>
<kwd>hereditary</kwd>
<kwd>HNPCC</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>pmc-status-qastatus</meta-name>
<meta-value>0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-status-live</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-status-embargo</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-status-released</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-open-access</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-olf</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-manuscript</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-legally-suppressed</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-has-pdf</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-has-supplement</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-pdf-only</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-suppress-copyright</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-is-real-version</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-is-scanned-article</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-preprint</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-in-epmc</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>